These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11796150)

  • 1. A study of the nicotinic agonist SIB-1553A on locomotion and attention as measured by the five-choice serial reaction time task.
    Grottick AJ; Wyler R; Higgins GA
    Pharmacol Biochem Behav; 2001 Dec; 70(4):505-13. PubMed ID: 11796150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive enhancing properties and tolerability of cholinergic agents in mice: a comparative study of nicotine, donepezil, and SIB-1553A, a subtype-selective ligand for nicotinic acetylcholine receptors.
    Bontempi B; Whelan KT; Risbrough VB; Lloyd GK; Menzaghi F
    Neuropsychopharmacology; 2003 Jul; 28(7):1235-46. PubMed ID: 12700710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro pharmacological characterization of (+/-)-4-[2-(1-methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride (SIB-1553A), a nicotinic acetylcholine receptor ligand.
    Rao TS; Adams PB; Correa LD; Santori EM; Sacaan AI; Reid RT; Suto CM; Vernier JM
    Brain Res; 2003 Aug; 981(1-2):85-98. PubMed ID: 12885429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of (+/-)-4-[[2-(1-methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride (SIB-1553A), a selective ligand for nicotinic acetylcholine receptors, in tests of visual attention and distractibility in rats and monkeys.
    Terry AV; Risbrough VB; Buccafusco JJ; Menzaghi F
    J Pharmacol Exp Ther; 2002 Apr; 301(1):284-92. PubMed ID: 11907185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIB-1553A, (+/-)-4-[[2-(1-methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride, a subtype-selective ligand for nicotinic acetylcholine receptors with putative cognitive-enhancing properties: effects on working and reference memory performances in aged rodents and nonhuman primates.
    Bontempi B; Whelan KT; Risbrough VB; Rao TS; Buccafusco JJ; Lloyd GK; Menzaghi F
    J Pharmacol Exp Ther; 2001 Oct; 299(1):297-306. PubMed ID: 11561092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The subtype-selective nicotinic acetylcholine receptor agonist SIB-1553A improves both attention and memory components of a spatial working memory task in chronic low dose 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys.
    Schneider JS; Tinker JP; Menzaghi F; Lloyd GK
    J Pharmacol Exp Ther; 2003 Jul; 306(1):401-6. PubMed ID: 12721323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo pharmacological characterization of (+/-)-4-[2-(1-methyl-2-pyrrolidinyl)ethyl]thiophenol hydrochloride (SIB-1553A), a novel cholinergic ligand: microdialysis studies.
    Rao TS; Reid RT; Correa LD; Santori EM; Gardner MF; Sacaan AI; Lorrain D; Vernier JM
    Brain Res; 2003 Oct; 986(1-2):71-81. PubMed ID: 12965231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task.
    Grottick AJ; Higgins GA
    Behav Brain Res; 2000 Dec; 117(1-2):197-208. PubMed ID: 11099773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nicotinic therapies on attention and executive functions in chronic low-dose MPTP-treated monkeys.
    Decamp E; Schneider JS
    Eur J Neurosci; 2006 Oct; 24(7):2098-104. PubMed ID: 17067307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of a vigilance decrement in the aged rat by subtype-selective nicotinic ligands.
    Grottick AJ; Haman M; Wyler R; Higgins GA
    Neuropsychopharmacology; 2003 May; 28(5):880-7. PubMed ID: 12637951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strain dependency of the effects of nicotine and mecamylamine in a rat model of attention.
    Hahn B; Riegger KE; Elmer GI
    Psychopharmacology (Berl); 2016 Apr; 233(8):1427-34. PubMed ID: 26875755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a novel cholinergic ion channel agonist SIB-1765F on locomotor activity in rats.
    Menzaghi F; Whelan KT; Risbrough VB; Rao TS; Lloyd GK
    J Pharmacol Exp Ther; 1997 Jan; 280(1):384-92. PubMed ID: 8996219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nicotine and mecamylamine on choice accuracy in an operant visual signal detection task in female rats.
    Rezvani AH; Bushnell PJ; Levin ED
    Psychopharmacology (Berl); 2002 Dec; 164(4):369-75. PubMed ID: 12457266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between nicotinic and dopaminergic therapies on cognition in a chronic Parkinson model.
    Decamp E; Schneider JS
    Brain Res; 2009 Mar; 1262():109-14. PubMed ID: 19368843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of nicotine-induced attentional enhancement in rats by adrenoceptor antagonists.
    Hahn B; Stolerman IP
    Psychopharmacology (Berl); 2005 Feb; 177(4):438-47. PubMed ID: 15252705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine in an animal model of attention.
    Stolerman IP; Mirza NR; Hahn B; Shoaib M
    Eur J Pharmacol; 2000 Mar; 393(1-3):147-54. PubMed ID: 10771008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization of SIB-1663, a conformationally rigid analog of nicotine.
    Rao TS; Sacaan AI; Menzaghi FM; Reid RT; Adams PB; Correa LD; Whelan KT; Vernier JM
    Brain Res; 2004 Apr; 1003(1-2):42-53. PubMed ID: 15019562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-[[2-(1-Methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride (SIB-1553A): a novel cognitive enhancer with selectivity for neuronal nicotinic acetylcholine receptors.
    Vernier JM; El-Abdellaoui H; Holsenback H; Cosford ND; Bleicher L; Barker G; Bontempi B; Chavez-Noriega L; Menzaghi F; Rao TS; Reid R; Sacaan AI; Suto C; Washburn M; Lloyd GK; McDonald IA
    J Med Chem; 1999 May; 42(10):1684-6. PubMed ID: 10346920
    [No Abstract]   [Full Text] [Related]  

  • 19. Different effects of ionotropic and metabotropic glutamate receptor antagonists on attention and the attentional properties of nicotine.
    Quarta D; Naylor CG; Morris HV; Patel S; Genn RF; Stolerman IP
    Neuropharmacology; 2007 Sep; 53(3):421-30. PubMed ID: 17631918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiosynthesis and ex vivo evaluation of [11C]-SIB-1553A as a PET radiotracer for beta4 selective subtype nicotinic acetylcholine receptor.
    Sobrio F; Quentin T; Dhilly M; Bourdier T; Tymciu S; Debruyne D; Barré L
    Nucl Med Biol; 2008 Apr; 35(3):377-85. PubMed ID: 18355694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.